Mid-market private equity firm Sun European Partners has maintained the heady pace of dealmaking that saw it complete a record number of transactions last year, by completing an acquisition in the pharmaceuticals sector, and remains confident that now is the time to do deals.

Michael Kalb, a senior managing director at the firm, declared, "It's a great time to buy companies which are set to benefit from general economic growth over the next few years".